If the patient has no renal failure, why is her potassium so high? Candesartan, spironolactone

Jennifer A. Rabbitts, Wayne T. Nicholson, Juraj Sprung

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This case discusses the pharmacodynamic interaction between candesartan and spironolactone, resulting in hyperkalemia. Candesartan is angiotensin II receptor blocker and spironolactone is a potassium-sparing diuretic.

Original languageEnglish (US)
Title of host publicationA Case Approach to Perioperative Drug-Drug Interactions
PublisherSpringer New York
Pages555-561
Number of pages7
ISBN (Electronic)9781461474951
ISBN (Print)9781461474944
DOIs
StatePublished - Sep 15 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'If the patient has no renal failure, why is her potassium so high? Candesartan, spironolactone'. Together they form a unique fingerprint.

  • Cite this

    Rabbitts, J. A., Nicholson, W. T., & Sprung, J. (2015). If the patient has no renal failure, why is her potassium so high? Candesartan, spironolactone. In A Case Approach to Perioperative Drug-Drug Interactions (pp. 555-561). Springer New York. https://doi.org/10.1007/978-1-4614-7495-1_123